Search Results For:
- Search results for:
- Gates Foundation – Icosavax, COVID-19 Vaccine Grant Agreement
(Click + to show provisions)
Agreement title
Effective date
Partner type
Technology
Development stage
Gates Foundation - Icosavax, COVID-19 Vaccine Grant Agreement
2021
Funder
Industry
Industry
Vaccine
Early clinical (through Phase 2)
Late clinical (Phase 3)
Late clinical (Phase 3)
- Equitable Access | Ensuring continuity
- Equitable Access | Access plans & principles
- Business model | Payment Structures
- Protecting & sharing information | Confidentiality
- Protecting & sharing information | Information sharing
- Protecting & sharing information | Publication of Results
- Intellectual Property | License Grants
- Liability | Indemnification & liability
- Liability | Insurance
- Liability | Representations & Warranties
- Term & termination | Effects of termination
- Term & termination | Term of agreement
- Term & termination | Termination & withdrawal
GHIAA2019\MapguideSearch Object
(
[search_parameters] => Array
(
[qs] => Gates Foundation – Icosavax, COVID-19 Vaccine Grant Agreement
)
[filters] => Array
(
[text_search] => Gates Foundation – Icosavax, COVID-19 Vaccine Grant Agreement
)
[child_filters] => Array
(
)
[agreement_args] =>
[provision_args] => Array
(
[post_type] => provision_document
[posts_per_page] => -1
[post__in] => Array
(
[0] => 5620
[1] => 5619
[2] => 5618
[3] => 5617
[4] => 5616
[5] => 5615
[6] => 5614
[7] => 5612
[8] => 5611
[9] => 5610
[10] => 5609
[11] => 5608
)
)
[text_agreement_args] => Array
(
[post_type] => agreement
[posts_per_page] => -1
[s] => Gates Foundation – Icosavax, COVID-19 Vaccine Grant Agreement
)
[text_provision_args] => Array
(
[post_type] => provision_document
[posts_per_page] => -1
[s] => Gates Foundation – Icosavax, COVID-19 Vaccine Grant Agreement
)
[agreement_ids] => Array
(
)
[agreement_q_rslts] =>
[provision_q_rslts] =>
[text_agreement_q_rslts] => WP_Query Object
(
[query] => Array
(
[post_type] => agreement
[posts_per_page] => -1
[s] => Gates Foundation – Icosavax, COVID-19 Vaccine Grant Agreement
)
[query_vars] => Array
(
[post_type] => agreement
[posts_per_page] => -1
[s] => Gates Foundation – Icosavax, COVID-19 Vaccine Grant Agreement
[error] =>
[m] =>
[p] => 0
[post_parent] =>
[subpost] =>
[subpost_id] =>
[attachment] =>
[attachment_id] => 0
[name] =>
[pagename] =>
[page_id] => 0
[second] =>
[minute] =>
[hour] =>
[day] => 0
[monthnum] => 0
[year] => 0
[w] => 0
[category_name] =>
[tag] =>
[cat] =>
[tag_id] =>
[author] =>
[author_name] =>
[feed] =>
[tb] =>
[paged] => 0
[meta_key] =>
[meta_value] =>
[preview] =>
[sentence] =>
[title] =>
[fields] =>
[menu_order] =>
[embed] =>
[category__in] => Array
(
)
[category__not_in] => Array
(
)
[category__and] => Array
(
)
[post__in] => Array
(
)
[post__not_in] => Array
(
)
[post_name__in] => Array
(
)
[tag__in] => Array
(
)
[tag__not_in] => Array
(
)
[tag__and] => Array
(
)
[tag_slug__in] => Array
(
)
[tag_slug__and] => Array
(
)
[post_parent__in] => Array
(
)
[post_parent__not_in] => Array
(
)
[author__in] => Array
(
)
[author__not_in] => Array
(
)
[orderby] => title
[order] => ASC
[suppress_filters] =>
[ignore_sticky_posts] =>
[cache_results] => 1
[update_post_term_cache] => 1
[update_menu_item_cache] =>
[lazy_load_term_meta] => 1
[update_post_meta_cache] => 1
[nopaging] => 1
[comments_per_page] => 50
[no_found_rows] =>
[search_terms_count] => 8
[search_terms] => Array
(
[0] => Gates
[1] => Foundation
[2] => –
[3] => Icosavax
[4] => COVID-19
[5] => Vaccine
[6] => Grant
[7] => Agreement
)
[search_orderby_title] => Array
(
[0] => wpry_posts.post_title LIKE '{c8a9d2b8eb86f6016ccb685e855c7132359c6a4d68ebf6da38a1637bba12a444}Gates{c8a9d2b8eb86f6016ccb685e855c7132359c6a4d68ebf6da38a1637bba12a444}'
[1] => wpry_posts.post_title LIKE '{c8a9d2b8eb86f6016ccb685e855c7132359c6a4d68ebf6da38a1637bba12a444}Foundation{c8a9d2b8eb86f6016ccb685e855c7132359c6a4d68ebf6da38a1637bba12a444}'
[2] => wpry_posts.post_title LIKE '{c8a9d2b8eb86f6016ccb685e855c7132359c6a4d68ebf6da38a1637bba12a444}–{c8a9d2b8eb86f6016ccb685e855c7132359c6a4d68ebf6da38a1637bba12a444}'
[3] => wpry_posts.post_title LIKE '{c8a9d2b8eb86f6016ccb685e855c7132359c6a4d68ebf6da38a1637bba12a444}Icosavax{c8a9d2b8eb86f6016ccb685e855c7132359c6a4d68ebf6da38a1637bba12a444}'
[4] => wpry_posts.post_title LIKE '{c8a9d2b8eb86f6016ccb685e855c7132359c6a4d68ebf6da38a1637bba12a444}COVID-19{c8a9d2b8eb86f6016ccb685e855c7132359c6a4d68ebf6da38a1637bba12a444}'
[5] => wpry_posts.post_title LIKE '{c8a9d2b8eb86f6016ccb685e855c7132359c6a4d68ebf6da38a1637bba12a444}Vaccine{c8a9d2b8eb86f6016ccb685e855c7132359c6a4d68ebf6da38a1637bba12a444}'
[6] => wpry_posts.post_title LIKE '{c8a9d2b8eb86f6016ccb685e855c7132359c6a4d68ebf6da38a1637bba12a444}Grant{c8a9d2b8eb86f6016ccb685e855c7132359c6a4d68ebf6da38a1637bba12a444}'
[7] => wpry_posts.post_title LIKE '{c8a9d2b8eb86f6016ccb685e855c7132359c6a4d68ebf6da38a1637bba12a444}Agreement{c8a9d2b8eb86f6016ccb685e855c7132359c6a4d68ebf6da38a1637bba12a444}'
)
)
[tax_query] => WP_Tax_Query Object
(
[queries] => Array
(
)
[relation] => AND
[table_aliases:protected] => Array
(
)
[queried_terms] => Array
(
)
[primary_table] => wpry_posts
[primary_id_column] => ID
)
[meta_query] => WP_Meta_Query Object
(
[queries] => Array
(
)
[relation] =>
[meta_table] =>
[meta_id_column] =>
[primary_table] =>
[primary_id_column] =>
[table_aliases:protected] => Array
(
)
[clauses:protected] => Array
(
)
[has_or_relation:protected] =>
)
[date_query] =>
[request] =>
SELECT DISTINCT wpry_posts.*
FROM wpry_posts INNER JOIN wpry_postmeta AS a ON ( a.post_id = wpry_posts.ID ) LEFT JOIN wpry_postmeta AS b ON ( (( b.post_id = a.post_id )) AND (( b.meta_key LIKE CONCAT( '\_', a.meta_key ) )) ) LEFT JOIN wpry_posts AS c ON ( ( c.post_name = b.meta_value ) AND ( c.post_type = 'acf-field' ) AND (( c.post_content LIKE '%:"text"%' ) OR ( c.post_content LIKE '%:"textarea"%' ) OR ( c.post_content LIKE '%:"wysiwyg"%' ) OR ( c.post_content LIKE '%:"checkbox"%' )) )
WHERE 1=1 AND ( ( ( b.meta_id IS NOT NULL ) AND ( c.ID IS NOT NULL ) AND ( a.meta_value LIKE '%Gates%' ) AND ( a.meta_value LIKE '%Foundation%' ) AND ( a.meta_value LIKE '%–%' ) AND ( a.meta_value LIKE '%Icosavax,%' ) AND ( a.meta_value LIKE '%COVID-19%' ) AND ( a.meta_value LIKE '%Vaccine%' ) AND ( a.meta_value LIKE '%Grant%' ) AND ( a.meta_value LIKE '%Agreement%' ) ) OR ( ( ( wpry_posts.post_title LIKE '%Gates%' ) OR ( wpry_posts.post_content LIKE '%Gates%' ) OR ( wpry_posts.post_excerpt LIKE '%Gates%' ) ) AND ( ( wpry_posts.post_title LIKE '%Foundation%' ) OR ( wpry_posts.post_content LIKE '%Foundation%' ) OR ( wpry_posts.post_excerpt LIKE '%Foundation%' ) ) AND ( ( wpry_posts.post_title LIKE '%–%' ) OR ( wpry_posts.post_content LIKE '%–%' ) OR ( wpry_posts.post_excerpt LIKE '%–%' ) ) AND ( ( wpry_posts.post_title LIKE '%Icosavax,%' ) OR ( wpry_posts.post_content LIKE '%Icosavax,%' ) OR ( wpry_posts.post_excerpt LIKE '%Icosavax,%' ) ) AND ( ( wpry_posts.post_title LIKE '%COVID-19%' ) OR ( wpry_posts.post_content LIKE '%COVID-19%' ) OR ( wpry_posts.post_excerpt LIKE '%COVID-19%' ) ) AND ( ( wpry_posts.post_title LIKE '%Vaccine%' ) OR ( wpry_posts.post_content LIKE '%Vaccine%' ) OR ( wpry_posts.post_excerpt LIKE '%Vaccine%' ) ) AND ( ( wpry_posts.post_title LIKE '%Grant%' ) OR ( wpry_posts.post_content LIKE '%Grant%' ) OR ( wpry_posts.post_excerpt LIKE '%Grant%' ) ) AND ( ( wpry_posts.post_title LIKE '%Agreement%' ) OR ( wpry_posts.post_content LIKE '%Agreement%' ) OR ( wpry_posts.post_excerpt LIKE '%Agreement%' ) ) ) ) AND ((wpry_posts.post_type = 'agreement' AND (wpry_posts.post_status = 'publish' OR wpry_posts.post_status = 'acf-disabled')))
ORDER BY wpry_posts.post_title ASC
[posts] => Array
(
)
[post_count] => 0
[current_post] => -1
[in_the_loop] =>
[comment_count] => 0
[current_comment] => -1
[found_posts] => 0
[max_num_pages] => 0
[max_num_comment_pages] => 0
[is_single] =>
[is_preview] =>
[is_page] =>
[is_archive] => 1
[is_date] =>
[is_year] =>
[is_month] =>
[is_day] =>
[is_time] =>
[is_author] =>
[is_category] =>
[is_tag] =>
[is_tax] =>
[is_search] => 1
[is_feed] =>
[is_comment_feed] =>
[is_trackback] =>
[is_home] =>
[is_privacy_policy] =>
[is_404] =>
[is_embed] =>
[is_paged] =>
[is_admin] =>
[is_attachment] =>
[is_singular] =>
[is_robots] =>
[is_favicon] =>
[is_posts_page] =>
[is_post_type_archive] => 1
[query_vars_hash:WP_Query:private] => 8ce4939a10642a43abf609f2c0a60f2f
[query_vars_changed:WP_Query:private] => 1
[thumbnails_cached] =>
[allow_query_attachment_by_filename:protected] =>
[stopwords:WP_Query:private] => Array
(
[0] => about
[1] => an
[2] => are
[3] => as
[4] => at
[5] => be
[6] => by
[7] => com
[8] => for
[9] => from
[10] => how
[11] => in
[12] => is
[13] => it
[14] => of
[15] => on
[16] => or
[17] => that
[18] => the
[19] => this
[20] => to
[21] => was
[22] => what
[23] => when
[24] => where
[25] => who
[26] => will
[27] => with
[28] => www
)
[compat_fields:WP_Query:private] => Array
(
[0] => query_vars_hash
[1] => query_vars_changed
)
[compat_methods:WP_Query:private] => Array
(
[0] => init_query_flags
[1] => parse_tax_query
)
)
[text_provision_q_rslts] => WP_Query Object
(
[query] => Array
(
[post_type] => provision_document
[posts_per_page] => -1
[s] => Gates Foundation – Icosavax, COVID-19 Vaccine Grant Agreement
)
[query_vars] => Array
(
[post_type] => provision_document
[posts_per_page] => -1
[s] => Gates Foundation – Icosavax, COVID-19 Vaccine Grant Agreement
[error] =>
[m] =>
[p] => 0
[post_parent] =>
[subpost] =>
[subpost_id] =>
[attachment] =>
[attachment_id] => 0
[name] =>
[pagename] =>
[page_id] => 0
[second] =>
[minute] =>
[hour] =>
[day] => 0
[monthnum] => 0
[year] => 0
[w] => 0
[category_name] =>
[tag] =>
[cat] =>
[tag_id] =>
[author] =>
[author_name] =>
[feed] =>
[tb] =>
[paged] => 0
[meta_key] =>
[meta_value] =>
[preview] =>
[sentence] =>
[title] =>
[fields] =>
[menu_order] =>
[embed] =>
[category__in] => Array
(
)
[category__not_in] => Array
(
)
[category__and] => Array
(
)
[post__in] => Array
(
)
[post__not_in] => Array
(
)
[post_name__in] => Array
(
)
[tag__in] => Array
(
)
[tag__not_in] => Array
(
)
[tag__and] => Array
(
)
[tag_slug__in] => Array
(
)
[tag_slug__and] => Array
(
)
[post_parent__in] => Array
(
)
[post_parent__not_in] => Array
(
)
[author__in] => Array
(
)
[author__not_in] => Array
(
)
[suppress_filters] =>
[ignore_sticky_posts] =>
[cache_results] => 1
[update_post_term_cache] => 1
[update_menu_item_cache] =>
[lazy_load_term_meta] => 1
[update_post_meta_cache] => 1
[nopaging] => 1
[comments_per_page] => 50
[no_found_rows] =>
[search_terms_count] => 8
[search_terms] => Array
(
[0] => Gates
[1] => Foundation
[2] => –
[3] => Icosavax
[4] => COVID-19
[5] => Vaccine
[6] => Grant
[7] => Agreement
)
[search_orderby_title] => Array
(
[0] => wpry_posts.post_title LIKE '{c8a9d2b8eb86f6016ccb685e855c7132359c6a4d68ebf6da38a1637bba12a444}Gates{c8a9d2b8eb86f6016ccb685e855c7132359c6a4d68ebf6da38a1637bba12a444}'
[1] => wpry_posts.post_title LIKE '{c8a9d2b8eb86f6016ccb685e855c7132359c6a4d68ebf6da38a1637bba12a444}Foundation{c8a9d2b8eb86f6016ccb685e855c7132359c6a4d68ebf6da38a1637bba12a444}'
[2] => wpry_posts.post_title LIKE '{c8a9d2b8eb86f6016ccb685e855c7132359c6a4d68ebf6da38a1637bba12a444}–{c8a9d2b8eb86f6016ccb685e855c7132359c6a4d68ebf6da38a1637bba12a444}'
[3] => wpry_posts.post_title LIKE '{c8a9d2b8eb86f6016ccb685e855c7132359c6a4d68ebf6da38a1637bba12a444}Icosavax{c8a9d2b8eb86f6016ccb685e855c7132359c6a4d68ebf6da38a1637bba12a444}'
[4] => wpry_posts.post_title LIKE '{c8a9d2b8eb86f6016ccb685e855c7132359c6a4d68ebf6da38a1637bba12a444}COVID-19{c8a9d2b8eb86f6016ccb685e855c7132359c6a4d68ebf6da38a1637bba12a444}'
[5] => wpry_posts.post_title LIKE '{c8a9d2b8eb86f6016ccb685e855c7132359c6a4d68ebf6da38a1637bba12a444}Vaccine{c8a9d2b8eb86f6016ccb685e855c7132359c6a4d68ebf6da38a1637bba12a444}'
[6] => wpry_posts.post_title LIKE '{c8a9d2b8eb86f6016ccb685e855c7132359c6a4d68ebf6da38a1637bba12a444}Grant{c8a9d2b8eb86f6016ccb685e855c7132359c6a4d68ebf6da38a1637bba12a444}'
[7] => wpry_posts.post_title LIKE '{c8a9d2b8eb86f6016ccb685e855c7132359c6a4d68ebf6da38a1637bba12a444}Agreement{c8a9d2b8eb86f6016ccb685e855c7132359c6a4d68ebf6da38a1637bba12a444}'
)
[order] => DESC
)
[tax_query] => WP_Tax_Query Object
(
[queries] => Array
(
)
[relation] => AND
[table_aliases:protected] => Array
(
)
[queried_terms] => Array
(
)
[primary_table] => wpry_posts
[primary_id_column] => ID
)
[meta_query] => WP_Meta_Query Object
(
[queries] => Array
(
)
[relation] =>
[meta_table] =>
[meta_id_column] =>
[primary_table] =>
[primary_id_column] =>
[table_aliases:protected] => Array
(
)
[clauses:protected] => Array
(
)
[has_or_relation:protected] =>
)
[date_query] =>
[request] =>
SELECT DISTINCT wpry_posts.*
FROM wpry_posts INNER JOIN wpry_postmeta AS a ON ( a.post_id = wpry_posts.ID ) LEFT JOIN wpry_postmeta AS b ON ( (( b.post_id = a.post_id )) AND (( b.meta_key LIKE CONCAT( '\_', a.meta_key ) )) ) LEFT JOIN wpry_posts AS c ON ( ( c.post_name = b.meta_value ) AND ( c.post_type = 'acf-field' ) AND (( c.post_content LIKE '%:"text"%' ) OR ( c.post_content LIKE '%:"textarea"%' ) OR ( c.post_content LIKE '%:"wysiwyg"%' ) OR ( c.post_content LIKE '%:"checkbox"%' )) )
WHERE 1=1 AND ( ( ( b.meta_id IS NOT NULL ) AND ( c.ID IS NOT NULL ) AND ( a.meta_value LIKE '%Gates%' ) AND ( a.meta_value LIKE '%Foundation%' ) AND ( a.meta_value LIKE '%–%' ) AND ( a.meta_value LIKE '%Icosavax,%' ) AND ( a.meta_value LIKE '%COVID-19%' ) AND ( a.meta_value LIKE '%Vaccine%' ) AND ( a.meta_value LIKE '%Grant%' ) AND ( a.meta_value LIKE '%Agreement%' ) ) OR ( ( ( wpry_posts.post_title LIKE '%Gates%' ) OR ( wpry_posts.post_content LIKE '%Gates%' ) OR ( wpry_posts.post_excerpt LIKE '%Gates%' ) ) AND ( ( wpry_posts.post_title LIKE '%Foundation%' ) OR ( wpry_posts.post_content LIKE '%Foundation%' ) OR ( wpry_posts.post_excerpt LIKE '%Foundation%' ) ) AND ( ( wpry_posts.post_title LIKE '%–%' ) OR ( wpry_posts.post_content LIKE '%–%' ) OR ( wpry_posts.post_excerpt LIKE '%–%' ) ) AND ( ( wpry_posts.post_title LIKE '%Icosavax,%' ) OR ( wpry_posts.post_content LIKE '%Icosavax,%' ) OR ( wpry_posts.post_excerpt LIKE '%Icosavax,%' ) ) AND ( ( wpry_posts.post_title LIKE '%COVID-19%' ) OR ( wpry_posts.post_content LIKE '%COVID-19%' ) OR ( wpry_posts.post_excerpt LIKE '%COVID-19%' ) ) AND ( ( wpry_posts.post_title LIKE '%Vaccine%' ) OR ( wpry_posts.post_content LIKE '%Vaccine%' ) OR ( wpry_posts.post_excerpt LIKE '%Vaccine%' ) ) AND ( ( wpry_posts.post_title LIKE '%Grant%' ) OR ( wpry_posts.post_content LIKE '%Grant%' ) OR ( wpry_posts.post_excerpt LIKE '%Grant%' ) ) AND ( ( wpry_posts.post_title LIKE '%Agreement%' ) OR ( wpry_posts.post_content LIKE '%Agreement%' ) OR ( wpry_posts.post_excerpt LIKE '%Agreement%' ) ) ) ) AND ((wpry_posts.post_type = 'provision_document' AND (wpry_posts.post_status = 'publish' OR wpry_posts.post_status = 'acf-disabled')))
ORDER BY (CASE WHEN wpry_posts.post_title LIKE '{c8a9d2b8eb86f6016ccb685e855c7132359c6a4d68ebf6da38a1637bba12a444}Gates Foundation – Icosavax, COVID-19 Vaccine Grant Agreement{c8a9d2b8eb86f6016ccb685e855c7132359c6a4d68ebf6da38a1637bba12a444}' THEN 1 WHEN wpry_posts.post_excerpt LIKE '{c8a9d2b8eb86f6016ccb685e855c7132359c6a4d68ebf6da38a1637bba12a444}Gates Foundation – Icosavax, COVID-19 Vaccine Grant Agreement{c8a9d2b8eb86f6016ccb685e855c7132359c6a4d68ebf6da38a1637bba12a444}' THEN 4 WHEN wpry_posts.post_content LIKE '{c8a9d2b8eb86f6016ccb685e855c7132359c6a4d68ebf6da38a1637bba12a444}Gates Foundation – Icosavax, COVID-19 Vaccine Grant Agreement{c8a9d2b8eb86f6016ccb685e855c7132359c6a4d68ebf6da38a1637bba12a444}' THEN 5 ELSE 6 END), wpry_posts.post_date DESC
[posts] => Array
(
[0] => WP_Post Object
(
[ID] => 5620
[post_author] => 5
[post_date] => 2022-08-12 12:05:12
[post_date_gmt] => 2022-08-12 12:05:12
[post_content] =>
[post_title] => Gates Foundation – Icosavax, COVID-19 Vaccine Grant Agreement
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => gates-foundation-icosavax-covid-19-vaccine-grant-agreement-12
[to_ping] =>
[pinged] =>
[post_modified] => 2022-08-12 12:05:12
[post_modified_gmt] => 2022-08-12 12:05:12
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.org/?post_type=provision_document&p=5620
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[1] => WP_Post Object
(
[ID] => 5619
[post_author] => 5
[post_date] => 2022-08-12 12:02:21
[post_date_gmt] => 2022-08-12 12:02:21
[post_content] =>
[post_title] => Gates Foundation – Icosavax, COVID-19 Vaccine Grant Agreement
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => gates-foundation-icosavax-covid-19-vaccine-grant-agreement-11
[to_ping] =>
[pinged] =>
[post_modified] => 2022-10-12 12:48:01
[post_modified_gmt] => 2022-10-12 12:48:01
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.org/?post_type=provision_document&p=5619
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[2] => WP_Post Object
(
[ID] => 5618
[post_author] => 5
[post_date] => 2022-08-12 11:52:17
[post_date_gmt] => 2022-08-12 11:52:17
[post_content] =>
[post_title] => Gates Foundation – Icosavax, COVID-19 Vaccine Grant Agreement
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => gates-foundation-icosavax-covid-19-vaccine-grant-agreement-10
[to_ping] =>
[pinged] =>
[post_modified] => 2022-08-12 11:52:17
[post_modified_gmt] => 2022-08-12 11:52:17
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.org/?post_type=provision_document&p=5618
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[3] => WP_Post Object
(
[ID] => 5617
[post_author] => 5
[post_date] => 2022-08-12 11:49:46
[post_date_gmt] => 2022-08-12 11:49:46
[post_content] =>
[post_title] => Gates Foundation – Icosavax, COVID-19 Vaccine Grant Agreement
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => gates-foundation-icosavax-covid-19-vaccine-grant-agreement-9
[to_ping] =>
[pinged] =>
[post_modified] => 2022-08-12 11:49:46
[post_modified_gmt] => 2022-08-12 11:49:46
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.org/?post_type=provision_document&p=5617
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[4] => WP_Post Object
(
[ID] => 5616
[post_author] => 5
[post_date] => 2022-08-12 11:45:22
[post_date_gmt] => 2022-08-12 11:45:22
[post_content] =>
[post_title] => Gates Foundation – Icosavax, COVID-19 Vaccine Grant Agreement
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => gates-foundation-icosavax-covid-19-vaccine-grant-agreement-8
[to_ping] =>
[pinged] =>
[post_modified] => 2022-08-12 11:45:22
[post_modified_gmt] => 2022-08-12 11:45:22
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.org/?post_type=provision_document&p=5616
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[5] => WP_Post Object
(
[ID] => 5615
[post_author] => 5
[post_date] => 2022-08-12 11:40:08
[post_date_gmt] => 2022-08-12 11:40:08
[post_content] =>
[post_title] => Gates Foundation – Icosavax, COVID-19 Vaccine Grant Agreement
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => gates-foundation-icosavax-covid-19-vaccine-grant-agreement-7
[to_ping] =>
[pinged] =>
[post_modified] => 2022-08-12 11:40:08
[post_modified_gmt] => 2022-08-12 11:40:08
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.org/?post_type=provision_document&p=5615
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[6] => WP_Post Object
(
[ID] => 5614
[post_author] => 5
[post_date] => 2022-08-12 11:34:41
[post_date_gmt] => 2022-08-12 11:34:41
[post_content] =>
[post_title] => Gates Foundation – Icosavax, COVID-19 Vaccine Grant Agreement
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => gates-foundation-icosavax-covid-19-vaccine-grant-agreement-6
[to_ping] =>
[pinged] =>
[post_modified] => 2022-09-29 11:28:05
[post_modified_gmt] => 2022-09-29 11:28:05
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.org/?post_type=provision_document&p=5614
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[7] => WP_Post Object
(
[ID] => 5612
[post_author] => 5
[post_date] => 2022-08-12 10:14:31
[post_date_gmt] => 2022-08-12 10:14:31
[post_content] =>
[post_title] => Gates Foundation – Icosavax, COVID-19 Vaccine Grant Agreement
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => gates-foundation-icosavax-covid-19-vaccine-grant-agreement-5
[to_ping] =>
[pinged] =>
[post_modified] => 2022-12-14 13:42:46
[post_modified_gmt] => 2022-12-14 13:42:46
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.org/?post_type=provision_document&p=5612
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[8] => WP_Post Object
(
[ID] => 5611
[post_author] => 5
[post_date] => 2022-08-12 10:05:33
[post_date_gmt] => 2022-08-12 10:05:33
[post_content] =>
[post_title] => Gates Foundation – Icosavax, COVID-19 Vaccine Grant Agreement
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => gates-foundation-icosavax-covid-19-vaccine-grant-agreement-4
[to_ping] =>
[pinged] =>
[post_modified] => 2022-08-12 10:05:33
[post_modified_gmt] => 2022-08-12 10:05:33
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.org/?post_type=provision_document&p=5611
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[9] => WP_Post Object
(
[ID] => 5610
[post_author] => 5
[post_date] => 2022-08-12 09:31:00
[post_date_gmt] => 2022-08-12 09:31:00
[post_content] =>
[post_title] => Gates Foundation – Icosavax, COVID-19 Vaccine Grant Agreement
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => gates-foundation-icosavax-covid-19-vaccine-grant-agreement-3
[to_ping] =>
[pinged] =>
[post_modified] => 2023-03-28 14:10:06
[post_modified_gmt] => 2023-03-28 14:10:06
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.org/?post_type=provision_document&p=5610
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[10] => WP_Post Object
(
[ID] => 5609
[post_author] => 5
[post_date] => 2022-08-12 09:24:43
[post_date_gmt] => 2022-08-12 09:24:43
[post_content] =>
[post_title] => Gates Foundation – Icosavax, COVID-19 Vaccine Grant Agreement
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => gates-foundation-icosavax-covid-19-vaccine-grant-agreement-2
[to_ping] =>
[pinged] =>
[post_modified] => 2022-08-12 09:24:43
[post_modified_gmt] => 2022-08-12 09:24:43
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.org/?post_type=provision_document&p=5609
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[11] => WP_Post Object
(
[ID] => 5608
[post_author] => 5
[post_date] => 2022-08-12 09:09:54
[post_date_gmt] => 2022-08-12 09:09:54
[post_content] =>
[post_title] => Gates Foundation – Icosavax, COVID-19 Vaccine Grant Agreement
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => gates-foundation-icosavax-covid-19-vaccine-grant-agreement
[to_ping] =>
[pinged] =>
[post_modified] => 2023-01-24 12:48:38
[post_modified_gmt] => 2023-01-24 12:48:38
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.org/?post_type=provision_document&p=5608
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
)
[post_count] => 12
[current_post] => -1
[in_the_loop] =>
[post] => WP_Post Object
(
[ID] => 5620
[post_author] => 5
[post_date] => 2022-08-12 12:05:12
[post_date_gmt] => 2022-08-12 12:05:12
[post_content] =>
[post_title] => Gates Foundation – Icosavax, COVID-19 Vaccine Grant Agreement
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => gates-foundation-icosavax-covid-19-vaccine-grant-agreement-12
[to_ping] =>
[pinged] =>
[post_modified] => 2022-08-12 12:05:12
[post_modified_gmt] => 2022-08-12 12:05:12
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.org/?post_type=provision_document&p=5620
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[comment_count] => 0
[current_comment] => -1
[found_posts] => 12
[max_num_pages] => 0
[max_num_comment_pages] => 0
[is_single] =>
[is_preview] =>
[is_page] =>
[is_archive] => 1
[is_date] =>
[is_year] =>
[is_month] =>
[is_day] =>
[is_time] =>
[is_author] =>
[is_category] =>
[is_tag] =>
[is_tax] =>
[is_search] => 1
[is_feed] =>
[is_comment_feed] =>
[is_trackback] =>
[is_home] =>
[is_privacy_policy] =>
[is_404] =>
[is_embed] =>
[is_paged] =>
[is_admin] =>
[is_attachment] =>
[is_singular] =>
[is_robots] =>
[is_favicon] =>
[is_posts_page] =>
[is_post_type_archive] => 1
[query_vars_hash:WP_Query:private] => aadb82b798d786bf75a32ea356d124ce
[query_vars_changed:WP_Query:private] => 1
[thumbnails_cached] =>
[allow_query_attachment_by_filename:protected] =>
[stopwords:WP_Query:private] => Array
(
[0] => about
[1] => an
[2] => are
[3] => as
[4] => at
[5] => be
[6] => by
[7] => com
[8] => for
[9] => from
[10] => how
[11] => in
[12] => is
[13] => it
[14] => of
[15] => on
[16] => or
[17] => that
[18] => the
[19] => this
[20] => to
[21] => was
[22] => what
[23] => when
[24] => where
[25] => who
[26] => will
[27] => with
[28] => www
)
[compat_fields:WP_Query:private] => Array
(
[0] => query_vars_hash
[1] => query_vars_changed
)
[compat_methods:WP_Query:private] => Array
(
[0] => init_query_flags
[1] => parse_tax_query
)
)
[provisions] => Array
(
[0] => WP_Post Object
(
[ID] => 5620
[post_author] => 5
[post_date] => 2022-08-12 12:05:12
[post_date_gmt] => 2022-08-12 12:05:12
[post_content] =>
[post_title] => Gates Foundation – Icosavax, COVID-19 Vaccine Grant Agreement
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => gates-foundation-icosavax-covid-19-vaccine-grant-agreement-12
[to_ping] =>
[pinged] =>
[post_modified] => 2022-08-12 12:05:12
[post_modified_gmt] => 2022-08-12 12:05:12
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.org/?post_type=provision_document&p=5620
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[1] => WP_Post Object
(
[ID] => 5619
[post_author] => 5
[post_date] => 2022-08-12 12:02:21
[post_date_gmt] => 2022-08-12 12:02:21
[post_content] =>
[post_title] => Gates Foundation – Icosavax, COVID-19 Vaccine Grant Agreement
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => gates-foundation-icosavax-covid-19-vaccine-grant-agreement-11
[to_ping] =>
[pinged] =>
[post_modified] => 2022-10-12 12:48:01
[post_modified_gmt] => 2022-10-12 12:48:01
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.org/?post_type=provision_document&p=5619
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[2] => WP_Post Object
(
[ID] => 5618
[post_author] => 5
[post_date] => 2022-08-12 11:52:17
[post_date_gmt] => 2022-08-12 11:52:17
[post_content] =>
[post_title] => Gates Foundation – Icosavax, COVID-19 Vaccine Grant Agreement
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => gates-foundation-icosavax-covid-19-vaccine-grant-agreement-10
[to_ping] =>
[pinged] =>
[post_modified] => 2022-08-12 11:52:17
[post_modified_gmt] => 2022-08-12 11:52:17
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.org/?post_type=provision_document&p=5618
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[3] => WP_Post Object
(
[ID] => 5617
[post_author] => 5
[post_date] => 2022-08-12 11:49:46
[post_date_gmt] => 2022-08-12 11:49:46
[post_content] =>
[post_title] => Gates Foundation – Icosavax, COVID-19 Vaccine Grant Agreement
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => gates-foundation-icosavax-covid-19-vaccine-grant-agreement-9
[to_ping] =>
[pinged] =>
[post_modified] => 2022-08-12 11:49:46
[post_modified_gmt] => 2022-08-12 11:49:46
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.org/?post_type=provision_document&p=5617
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[4] => WP_Post Object
(
[ID] => 5616
[post_author] => 5
[post_date] => 2022-08-12 11:45:22
[post_date_gmt] => 2022-08-12 11:45:22
[post_content] =>
[post_title] => Gates Foundation – Icosavax, COVID-19 Vaccine Grant Agreement
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => gates-foundation-icosavax-covid-19-vaccine-grant-agreement-8
[to_ping] =>
[pinged] =>
[post_modified] => 2022-08-12 11:45:22
[post_modified_gmt] => 2022-08-12 11:45:22
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.org/?post_type=provision_document&p=5616
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[5] => WP_Post Object
(
[ID] => 5615
[post_author] => 5
[post_date] => 2022-08-12 11:40:08
[post_date_gmt] => 2022-08-12 11:40:08
[post_content] =>
[post_title] => Gates Foundation – Icosavax, COVID-19 Vaccine Grant Agreement
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => gates-foundation-icosavax-covid-19-vaccine-grant-agreement-7
[to_ping] =>
[pinged] =>
[post_modified] => 2022-08-12 11:40:08
[post_modified_gmt] => 2022-08-12 11:40:08
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.org/?post_type=provision_document&p=5615
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[6] => WP_Post Object
(
[ID] => 5614
[post_author] => 5
[post_date] => 2022-08-12 11:34:41
[post_date_gmt] => 2022-08-12 11:34:41
[post_content] =>
[post_title] => Gates Foundation – Icosavax, COVID-19 Vaccine Grant Agreement
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => gates-foundation-icosavax-covid-19-vaccine-grant-agreement-6
[to_ping] =>
[pinged] =>
[post_modified] => 2022-09-29 11:28:05
[post_modified_gmt] => 2022-09-29 11:28:05
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.org/?post_type=provision_document&p=5614
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[7] => WP_Post Object
(
[ID] => 5612
[post_author] => 5
[post_date] => 2022-08-12 10:14:31
[post_date_gmt] => 2022-08-12 10:14:31
[post_content] =>
[post_title] => Gates Foundation – Icosavax, COVID-19 Vaccine Grant Agreement
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => gates-foundation-icosavax-covid-19-vaccine-grant-agreement-5
[to_ping] =>
[pinged] =>
[post_modified] => 2022-12-14 13:42:46
[post_modified_gmt] => 2022-12-14 13:42:46
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.org/?post_type=provision_document&p=5612
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[8] => WP_Post Object
(
[ID] => 5611
[post_author] => 5
[post_date] => 2022-08-12 10:05:33
[post_date_gmt] => 2022-08-12 10:05:33
[post_content] =>
[post_title] => Gates Foundation – Icosavax, COVID-19 Vaccine Grant Agreement
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => gates-foundation-icosavax-covid-19-vaccine-grant-agreement-4
[to_ping] =>
[pinged] =>
[post_modified] => 2022-08-12 10:05:33
[post_modified_gmt] => 2022-08-12 10:05:33
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.org/?post_type=provision_document&p=5611
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[9] => WP_Post Object
(
[ID] => 5610
[post_author] => 5
[post_date] => 2022-08-12 09:31:00
[post_date_gmt] => 2022-08-12 09:31:00
[post_content] =>
[post_title] => Gates Foundation – Icosavax, COVID-19 Vaccine Grant Agreement
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => gates-foundation-icosavax-covid-19-vaccine-grant-agreement-3
[to_ping] =>
[pinged] =>
[post_modified] => 2023-03-28 14:10:06
[post_modified_gmt] => 2023-03-28 14:10:06
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.org/?post_type=provision_document&p=5610
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[10] => WP_Post Object
(
[ID] => 5609
[post_author] => 5
[post_date] => 2022-08-12 09:24:43
[post_date_gmt] => 2022-08-12 09:24:43
[post_content] =>
[post_title] => Gates Foundation – Icosavax, COVID-19 Vaccine Grant Agreement
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => gates-foundation-icosavax-covid-19-vaccine-grant-agreement-2
[to_ping] =>
[pinged] =>
[post_modified] => 2022-08-12 09:24:43
[post_modified_gmt] => 2022-08-12 09:24:43
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.org/?post_type=provision_document&p=5609
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[11] => WP_Post Object
(
[ID] => 5608
[post_author] => 5
[post_date] => 2022-08-12 09:09:54
[post_date_gmt] => 2022-08-12 09:09:54
[post_content] =>
[post_title] => Gates Foundation – Icosavax, COVID-19 Vaccine Grant Agreement
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => gates-foundation-icosavax-covid-19-vaccine-grant-agreement
[to_ping] =>
[pinged] =>
[post_modified] => 2023-01-24 12:48:38
[post_modified_gmt] => 2023-01-24 12:48:38
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://ghiaa.org/?post_type=provision_document&p=5608
[menu_order] => 0
[post_type] => provision_document
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
)
[invalid_get] =>
[is_text_search] => 1
[has_agreement_filters] =>
[has_any_agreement_filter] => Array
(
)
[found_agreements] =>
[has_provision_filters] =>
[found_provisions] => 1
[lbl_quick_search:GHIAA2019\MapguideSearch:private] => Search results for:
[lbl_issue:GHIAA2019\MapguideSearch:private] => Issue:
[lbl_key_term:GHIAA2019\MapguideSearch:private] => Key Term:
[lbl_agreement_type:GHIAA2019\MapguideSearch:private] => Agreement Type:
[lbl_partner_type:GHIAA2019\MapguideSearch:private] => Partner Type:
[lbl_technology:GHIAA2019\MapguideSearch:private] => Technology:
[lbl_development_stage:GHIAA2019\MapguideSearch:private] => Development Stage:
[issues_by_id:GHIAA2019\MapguideSearch:private] => Array
(
[101] => WP_Term Object
(
[term_id] => 101
[name] => Access plans & principles
[slug] => equitable-access
[term_group] => 0
[term_taxonomy_id] => 101
[taxonomy] => issue
[description] =>
[parent] => 46
[count] => 29
[filter] => raw
[parent_name] => Equitable Access
[parent_slug] => access-to-medicines
)
[100] => WP_Term Object
(
[term_id] => 100
[name] => Affordable pricing
[slug] => pricing
[term_group] => 0
[term_taxonomy_id] => 100
[taxonomy] => issue
[description] =>
[parent] => 46
[count] => 28
[filter] => raw
[parent_name] => Equitable Access
[parent_slug] => access-to-medicines
)
[66] => WP_Term Object
(
[term_id] => 66
[name] => Benefit sharing
[slug] => benefit-revenue-sharing
[term_group] => 0
[term_taxonomy_id] => 66
[taxonomy] => issue
[description] =>
[parent] => 53
[count] => 9
[filter] => raw
[parent_name] => Business model
[parent_slug] => business-model
)
[53] => WP_Term Object
(
[term_id] => 53
[name] => Business model
[slug] => business-model
[term_group] => 0
[term_taxonomy_id] => 53
[taxonomy] => issue
[description] =>
[parent] => 0
[count] => 0
[filter] => raw
[parent_name] =>
[parent_slug] =>
)
[84] => WP_Term Object
(
[term_id] => 84
[name] => Confidentiality
[slug] => confidentiality
[term_group] => 0
[term_taxonomy_id] => 84
[taxonomy] => issue
[description] =>
[parent] => 49
[count] => 65
[filter] => raw
[parent_name] => Protecting & sharing information
[parent_slug] => information-sharing
)
[271] => WP_Term Object
(
[term_id] => 271
[name] => Donation
[slug] => donation
[term_group] => 0
[term_taxonomy_id] => 271
[taxonomy] => issue
[description] =>
[parent] => 46
[count] => 5
[filter] => raw
[parent_name] => Equitable Access
[parent_slug] => access-to-medicines
)
[72] => WP_Term Object
(
[term_id] => 72
[name] => Effects of termination
[slug] => effect-of-termination
[term_group] => 0
[term_taxonomy_id] => 72
[taxonomy] => issue
[description] =>
[parent] => 52
[count] => 49
[filter] => raw
[parent_name] => Term & termination
[parent_slug] => term-and-termination
)
[281] => WP_Term Object
(
[term_id] => 281
[name] => Ensuring continuity
[slug] => ensuring-continuity
[term_group] => 0
[term_taxonomy_id] => 281
[taxonomy] => issue
[description] =>
[parent] => 46
[count] => 34
[filter] => raw
[parent_name] => Equitable Access
[parent_slug] => access-to-medicines
)
[46] => WP_Term Object
(
[term_id] => 46
[name] => Equitable Access
[slug] => access-to-medicines
[term_group] => 0
[term_taxonomy_id] => 46
[taxonomy] => issue
[description] =>
[parent] => 0
[count] => 0
[filter] => raw
[parent_name] =>
[parent_slug] =>
)
[278] => WP_Term Object
(
[term_id] => 278
[name] => Governance
[slug] => roles-responsibilities
[term_group] => 0
[term_taxonomy_id] => 278
[taxonomy] => issue
[description] =>
[parent] => 53
[count] => 51
[filter] => raw
[parent_name] => Business model
[parent_slug] => business-model
)
[80] => WP_Term Object
(
[term_id] => 80
[name] => Indemnification & liability
[slug] => indemnity
[term_group] => 0
[term_taxonomy_id] => 80
[taxonomy] => issue
[description] =>
[parent] => 50
[count] => 65
[filter] => raw
[parent_name] => Liability
[parent_slug] => liability
)
[257] => WP_Term Object
(
[term_id] => 257
[name] => Information sharing
[slug] => information-sharing-information-sharing
[term_group] => 0
[term_taxonomy_id] => 257
[taxonomy] => issue
[description] =>
[parent] => 49
[count] => 55
[filter] => raw
[parent_name] => Protecting & sharing information
[parent_slug] => information-sharing
)
[109] => WP_Term Object
(
[term_id] => 109
[name] => Insurance
[slug] => insurance
[term_group] => 0
[term_taxonomy_id] => 109
[taxonomy] => issue
[description] =>
[parent] => 50
[count] => 37
[filter] => raw
[parent_name] => Liability
[parent_slug] => liability
)
[48] => WP_Term Object
(
[term_id] => 48
[name] => Intellectual Property
[slug] => ip-ownership
[term_group] => 0
[term_taxonomy_id] => 48
[taxonomy] => issue
[description] =>
[parent] => 0
[count] => 0
[filter] => raw
[parent_name] =>
[parent_slug] =>
)
[50] => WP_Term Object
(
[term_id] => 50
[name] => Liability
[slug] => liability
[term_group] => 0
[term_taxonomy_id] => 50
[taxonomy] => issue
[description] =>
[parent] => 0
[count] => 0
[filter] => raw
[parent_name] =>
[parent_slug] =>
)
[88] => WP_Term Object
(
[term_id] => 88
[name] => License Grants
[slug] => license-grants
[term_group] => 0
[term_taxonomy_id] => 88
[taxonomy] => issue
[description] =>
[parent] => 48
[count] => 66
[filter] => raw
[parent_name] => Intellectual Property
[parent_slug] => ip-ownership
)
[87] => WP_Term Object
(
[term_id] => 87
[name] => Ownership of IP
[slug] => ownership-ip
[term_group] => 0
[term_taxonomy_id] => 87
[taxonomy] => issue
[description] =>
[parent] => 48
[count] => 53
[filter] => raw
[parent_name] => Intellectual Property
[parent_slug] => ip-ownership
)
[70] => WP_Term Object
(
[term_id] => 70
[name] => Payment Structures
[slug] => royalties-and-payments
[term_group] => 0
[term_taxonomy_id] => 70
[taxonomy] => issue
[description] =>
[parent] => 53
[count] => 50
[filter] => raw
[parent_name] => Business model
[parent_slug] => business-model
)
[102] => WP_Term Object
(
[term_id] => 102
[name] => Preparedness & response
[slug] => outbreak-preparedness
[term_group] => 0
[term_taxonomy_id] => 102
[taxonomy] => issue
[description] =>
[parent] => 46
[count] => 9
[filter] => raw
[parent_name] => Equitable Access
[parent_slug] => access-to-medicines
)
[268] => WP_Term Object
(
[term_id] => 268
[name] => Product supply
[slug] => supply-purchase-of-products
[term_group] => 0
[term_taxonomy_id] => 268
[taxonomy] => issue
[description] =>
[parent] => 53
[count] => 30
[filter] => raw
[parent_name] => Business model
[parent_slug] => business-model
)
[49] => WP_Term Object
(
[term_id] => 49
[name] => Protecting & sharing information
[slug] => information-sharing
[term_group] => 0
[term_taxonomy_id] => 49
[taxonomy] => issue
[description] =>
[parent] => 0
[count] => 0
[filter] => raw
[parent_name] =>
[parent_slug] =>
)
[90] => WP_Term Object
(
[term_id] => 90
[name] => Protection of IP
[slug] => protection-results
[term_group] => 0
[term_taxonomy_id] => 90
[taxonomy] => issue
[description] =>
[parent] => 48
[count] => 42
[filter] => raw
[parent_name] => Intellectual Property
[parent_slug] => ip-ownership
)
[290] => WP_Term Object
(
[term_id] => 290
[name] => Publication of Results
[slug] => publication-of-results
[term_group] => 0
[term_taxonomy_id] => 290
[taxonomy] => issue
[description] =>
[parent] => 49
[count] => 39
[filter] => raw
[parent_name] => Protecting & sharing information
[parent_slug] => information-sharing
)
[56] => WP_Term Object
(
[term_id] => 56
[name] => Regulatory strategy
[slug] => regulatory-strategy
[term_group] => 0
[term_taxonomy_id] => 56
[taxonomy] => issue
[description] =>
[parent] => 53
[count] => 37
[filter] => raw
[parent_name] => Business model
[parent_slug] => business-model
)
[81] => WP_Term Object
(
[term_id] => 81
[name] => Representations & Warranties
[slug] => warranties
[term_group] => 0
[term_taxonomy_id] => 81
[taxonomy] => issue
[description] =>
[parent] => 50
[count] => 56
[filter] => raw
[parent_name] => Liability
[parent_slug] => liability
)
[86] => WP_Term Object
(
[term_id] => 86
[name] => Technology transfer
[slug] => technology-transfer
[term_group] => 0
[term_taxonomy_id] => 86
[taxonomy] => issue
[description] =>
[parent] => 49
[count] => 25
[filter] => raw
[parent_name] => Protecting & sharing information
[parent_slug] => information-sharing
)
[52] => WP_Term Object
(
[term_id] => 52
[name] => Term & termination
[slug] => term-and-termination
[term_group] => 0
[term_taxonomy_id] => 52
[taxonomy] => issue
[description] =>
[parent] => 0
[count] => 0
[filter] => raw
[parent_name] =>
[parent_slug] =>
)
[76] => WP_Term Object
(
[term_id] => 76
[name] => Term of agreement
[slug] => term-of-agreement
[term_group] => 0
[term_taxonomy_id] => 76
[taxonomy] => issue
[description] =>
[parent] => 52
[count] => 53
[filter] => raw
[parent_name] => Term & termination
[parent_slug] => term-and-termination
)
[74] => WP_Term Object
(
[term_id] => 74
[name] => Termination & withdrawal
[slug] => termination-and-withdrawal
[term_group] => 0
[term_taxonomy_id] => 74
[taxonomy] => issue
[description] =>
[parent] => 52
[count] => 51
[filter] => raw
[parent_name] => Term & termination
[parent_slug] => term-and-termination
)
[282] => WP_Term Object
(
[term_id] => 282
[name] => Territory access commitments
[slug] => territory-access-commitments
[term_group] => 0
[term_taxonomy_id] => 282
[taxonomy] => issue
[description] =>
[parent] => 46
[count] => 33
[filter] => raw
[parent_name] => Equitable Access
[parent_slug] => access-to-medicines
)
)
[issues_by_slug:GHIAA2019\MapguideSearch:private] => Array
(
[equitable-access] => WP_Term Object
(
[term_id] => 101
[name] => Access plans & principles
[slug] => equitable-access
[term_group] => 0
[term_taxonomy_id] => 101
[taxonomy] => issue
[description] =>
[parent] => 46
[count] => 29
[filter] => raw
[parent_name] => Equitable Access
[parent_slug] => access-to-medicines
)
[pricing] => WP_Term Object
(
[term_id] => 100
[name] => Affordable pricing
[slug] => pricing
[term_group] => 0
[term_taxonomy_id] => 100
[taxonomy] => issue
[description] =>
[parent] => 46
[count] => 28
[filter] => raw
[parent_name] => Equitable Access
[parent_slug] => access-to-medicines
)
[benefit-revenue-sharing] => WP_Term Object
(
[term_id] => 66
[name] => Benefit sharing
[slug] => benefit-revenue-sharing
[term_group] => 0
[term_taxonomy_id] => 66
[taxonomy] => issue
[description] =>
[parent] => 53
[count] => 9
[filter] => raw
[parent_name] => Business model
[parent_slug] => business-model
)
[business-model] => WP_Term Object
(
[term_id] => 53
[name] => Business model
[slug] => business-model
[term_group] => 0
[term_taxonomy_id] => 53
[taxonomy] => issue
[description] =>
[parent] => 0
[count] => 0
[filter] => raw
[parent_name] =>
[parent_slug] =>
)
[confidentiality] => WP_Term Object
(
[term_id] => 84
[name] => Confidentiality
[slug] => confidentiality
[term_group] => 0
[term_taxonomy_id] => 84
[taxonomy] => issue
[description] =>
[parent] => 49
[count] => 65
[filter] => raw
[parent_name] => Protecting & sharing information
[parent_slug] => information-sharing
)
[donation] => WP_Term Object
(
[term_id] => 271
[name] => Donation
[slug] => donation
[term_group] => 0
[term_taxonomy_id] => 271
[taxonomy] => issue
[description] =>
[parent] => 46
[count] => 5
[filter] => raw
[parent_name] => Equitable Access
[parent_slug] => access-to-medicines
)
[effect-of-termination] => WP_Term Object
(
[term_id] => 72
[name] => Effects of termination
[slug] => effect-of-termination
[term_group] => 0
[term_taxonomy_id] => 72
[taxonomy] => issue
[description] =>
[parent] => 52
[count] => 49
[filter] => raw
[parent_name] => Term & termination
[parent_slug] => term-and-termination
)
[ensuring-continuity] => WP_Term Object
(
[term_id] => 281
[name] => Ensuring continuity
[slug] => ensuring-continuity
[term_group] => 0
[term_taxonomy_id] => 281
[taxonomy] => issue
[description] =>
[parent] => 46
[count] => 34
[filter] => raw
[parent_name] => Equitable Access
[parent_slug] => access-to-medicines
)
[access-to-medicines] => WP_Term Object
(
[term_id] => 46
[name] => Equitable Access
[slug] => access-to-medicines
[term_group] => 0
[term_taxonomy_id] => 46
[taxonomy] => issue
[description] =>
[parent] => 0
[count] => 0
[filter] => raw
[parent_name] =>
[parent_slug] =>
)
[roles-responsibilities] => WP_Term Object
(
[term_id] => 278
[name] => Governance
[slug] => roles-responsibilities
[term_group] => 0
[term_taxonomy_id] => 278
[taxonomy] => issue
[description] =>
[parent] => 53
[count] => 51
[filter] => raw
[parent_name] => Business model
[parent_slug] => business-model
)
[indemnity] => WP_Term Object
(
[term_id] => 80
[name] => Indemnification & liability
[slug] => indemnity
[term_group] => 0
[term_taxonomy_id] => 80
[taxonomy] => issue
[description] =>
[parent] => 50
[count] => 65
[filter] => raw
[parent_name] => Liability
[parent_slug] => liability
)
[information-sharing-information-sharing] => WP_Term Object
(
[term_id] => 257
[name] => Information sharing
[slug] => information-sharing-information-sharing
[term_group] => 0
[term_taxonomy_id] => 257
[taxonomy] => issue
[description] =>
[parent] => 49
[count] => 55
[filter] => raw
[parent_name] => Protecting & sharing information
[parent_slug] => information-sharing
)
[insurance] => WP_Term Object
(
[term_id] => 109
[name] => Insurance
[slug] => insurance
[term_group] => 0
[term_taxonomy_id] => 109
[taxonomy] => issue
[description] =>
[parent] => 50
[count] => 37
[filter] => raw
[parent_name] => Liability
[parent_slug] => liability
)
[ip-ownership] => WP_Term Object
(
[term_id] => 48
[name] => Intellectual Property
[slug] => ip-ownership
[term_group] => 0
[term_taxonomy_id] => 48
[taxonomy] => issue
[description] =>
[parent] => 0
[count] => 0
[filter] => raw
[parent_name] =>
[parent_slug] =>
)
[liability] => WP_Term Object
(
[term_id] => 50
[name] => Liability
[slug] => liability
[term_group] => 0
[term_taxonomy_id] => 50
[taxonomy] => issue
[description] =>
[parent] => 0
[count] => 0
[filter] => raw
[parent_name] =>
[parent_slug] =>
)
[license-grants] => WP_Term Object
(
[term_id] => 88
[name] => License Grants
[slug] => license-grants
[term_group] => 0
[term_taxonomy_id] => 88
[taxonomy] => issue
[description] =>
[parent] => 48
[count] => 66
[filter] => raw
[parent_name] => Intellectual Property
[parent_slug] => ip-ownership
)
[ownership-ip] => WP_Term Object
(
[term_id] => 87
[name] => Ownership of IP
[slug] => ownership-ip
[term_group] => 0
[term_taxonomy_id] => 87
[taxonomy] => issue
[description] =>
[parent] => 48
[count] => 53
[filter] => raw
[parent_name] => Intellectual Property
[parent_slug] => ip-ownership
)
[royalties-and-payments] => WP_Term Object
(
[term_id] => 70
[name] => Payment Structures
[slug] => royalties-and-payments
[term_group] => 0
[term_taxonomy_id] => 70
[taxonomy] => issue
[description] =>
[parent] => 53
[count] => 50
[filter] => raw
[parent_name] => Business model
[parent_slug] => business-model
)
[outbreak-preparedness] => WP_Term Object
(
[term_id] => 102
[name] => Preparedness & response
[slug] => outbreak-preparedness
[term_group] => 0
[term_taxonomy_id] => 102
[taxonomy] => issue
[description] =>
[parent] => 46
[count] => 9
[filter] => raw
[parent_name] => Equitable Access
[parent_slug] => access-to-medicines
)
[supply-purchase-of-products] => WP_Term Object
(
[term_id] => 268
[name] => Product supply
[slug] => supply-purchase-of-products
[term_group] => 0
[term_taxonomy_id] => 268
[taxonomy] => issue
[description] =>
[parent] => 53
[count] => 30
[filter] => raw
[parent_name] => Business model
[parent_slug] => business-model
)
[information-sharing] => WP_Term Object
(
[term_id] => 49
[name] => Protecting & sharing information
[slug] => information-sharing
[term_group] => 0
[term_taxonomy_id] => 49
[taxonomy] => issue
[description] =>
[parent] => 0
[count] => 0
[filter] => raw
[parent_name] =>
[parent_slug] =>
)
[protection-results] => WP_Term Object
(
[term_id] => 90
[name] => Protection of IP
[slug] => protection-results
[term_group] => 0
[term_taxonomy_id] => 90
[taxonomy] => issue
[description] =>
[parent] => 48
[count] => 42
[filter] => raw
[parent_name] => Intellectual Property
[parent_slug] => ip-ownership
)
[publication-of-results] => WP_Term Object
(
[term_id] => 290
[name] => Publication of Results
[slug] => publication-of-results
[term_group] => 0
[term_taxonomy_id] => 290
[taxonomy] => issue
[description] =>
[parent] => 49
[count] => 39
[filter] => raw
[parent_name] => Protecting & sharing information
[parent_slug] => information-sharing
)
[regulatory-strategy] => WP_Term Object
(
[term_id] => 56
[name] => Regulatory strategy
[slug] => regulatory-strategy
[term_group] => 0
[term_taxonomy_id] => 56
[taxonomy] => issue
[description] =>
[parent] => 53
[count] => 37
[filter] => raw
[parent_name] => Business model
[parent_slug] => business-model
)
[warranties] => WP_Term Object
(
[term_id] => 81
[name] => Representations & Warranties
[slug] => warranties
[term_group] => 0
[term_taxonomy_id] => 81
[taxonomy] => issue
[description] =>
[parent] => 50
[count] => 56
[filter] => raw
[parent_name] => Liability
[parent_slug] => liability
)
[technology-transfer] => WP_Term Object
(
[term_id] => 86
[name] => Technology transfer
[slug] => technology-transfer
[term_group] => 0
[term_taxonomy_id] => 86
[taxonomy] => issue
[description] =>
[parent] => 49
[count] => 25
[filter] => raw
[parent_name] => Protecting & sharing information
[parent_slug] => information-sharing
)
[term-and-termination] => WP_Term Object
(
[term_id] => 52
[name] => Term & termination
[slug] => term-and-termination
[term_group] => 0
[term_taxonomy_id] => 52
[taxonomy] => issue
[description] =>
[parent] => 0
[count] => 0
[filter] => raw
[parent_name] =>
[parent_slug] =>
)
[term-of-agreement] => WP_Term Object
(
[term_id] => 76
[name] => Term of agreement
[slug] => term-of-agreement
[term_group] => 0
[term_taxonomy_id] => 76
[taxonomy] => issue
[description] =>
[parent] => 52
[count] => 53
[filter] => raw
[parent_name] => Term & termination
[parent_slug] => term-and-termination
)
[termination-and-withdrawal] => WP_Term Object
(
[term_id] => 74
[name] => Termination & withdrawal
[slug] => termination-and-withdrawal
[term_group] => 0
[term_taxonomy_id] => 74
[taxonomy] => issue
[description] =>
[parent] => 52
[count] => 51
[filter] => raw
[parent_name] => Term & termination
[parent_slug] => term-and-termination
)
[territory-access-commitments] => WP_Term Object
(
[term_id] => 282
[name] => Territory access commitments
[slug] => territory-access-commitments
[term_group] => 0
[term_taxonomy_id] => 282
[taxonomy] => issue
[description] =>
[parent] => 46
[count] => 33
[filter] => raw
[parent_name] => Equitable Access
[parent_slug] => access-to-medicines
)
)
[filter_issues:GHIAA2019\MapguideSearch:private] => Array
(
)
)
